Taking advantage of data and trustworthy collaboration is the way to go when it comes to a life- and disease course approach to health protection and chronic care, argues Prof Dr Freimut Schliess, Director of Science & Innovation at Profil GmbH.
DiaChemo is a European project developing a platform technology for point-of-care devices for therapeutic drug monitoring in cancer treatment and beyond, reveals Dr Silke Krol, Head of the Translational Nanotechnology Lab and Coordinator of the DIACHEMO Project.
The UK is set to train many more highly skilled engineers in prosthetics and orthotics following the announcement of a new global centre of excellence based at the University of Salford.
Michael Roth, Research Group Leader at University Hospital Basel asks if disturbed cell-cell interaction causes asthma and provides a fascinating response.
The Department of Health in Northern Ireland pledge to replace the bowel cancer screening test in the country with the new, more accurate Faecal Immunochemical Test (FIT) from early 2020.
Ramya Sriram, manager at Kolabtree, explains why many patients in the UK still cannot access medical cannabis and how scientific communication and further research can lead to change.
Henry Jones spoke to Nishat from Open Access Government about mental health platform Big White Wall (BWW), in light of expected UK Government White Paper on Online Harms.
Around 1 in 15 people affected by Tuberculosis (TB) are likely to get the treatable fungal infection Aspergillosis, according to TB research by The University of Manchester and Gulu Referral Hospital, Uganda.
We all know that a woman’s fertility decreases as she gets older, and the quality and number of her eggs decline: why is there a ten-year limit on egg freezing?
Professor Dame Pamela Shaw explains how the National Institute for Health Research (NIHR) supports experimental medicine and translational research in neurodegenerative diseases.
Professor John Wilding from the University of Liverpool discusses how more effective use of treatments and greater support for healthcare professionals can make the difference in the battle against Type 2 diabetes
Heinz Zwierzina M.D., CDDF Managing Director tells us all about biomarkers and patients’ access to personalised oncology drugs in Europe in this insightful article
